Hyperplasia Clinical Trial
— TRECOfficial title:
TREC - Evaluation of the Impact of Eversion Technical Features on the Rate of Carotid Restenosis
Restenosis due to myo-intimal hyperplasia remains a concern after carotid endarterectomy. It occurs in around 6% of cases. Several risk factors for restenosis have already been identified, such as smoking, hypertension, female gender, diabetes, dyslipidemia and small carotid diameter. The main objective of this prospective multicenter study was to determine whether the technical characteristics of the eversion technique have an influence on the rate of restenosis at 1 year. Between September 2021 and November 2022, we followed all patients undergoing carotid endarterectomy by eversion in 8 French hospitals. Demographic data, operative indications and technical characteristics of the endarterectomies performed were collected. These were defined by the circumferential nature of the carotid bulb according to 3 types (TREC A, B or C), and the length and depth of the endarterectomy according to anatomopathological reports. Post-operative complications were collected as much as doppler ultrasonography at three months and 1 year to quantify restenosis.
Status | Not yet recruiting |
Enrollment | 500 |
Est. completion date | June 1, 2024 |
Est. primary completion date | June 1, 2024 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: Any patient who is having carotid endarterectomy by eversion according to HAS + ESVS recommendations : - Stenosis > 70% on dopplerin the absence of neurological symptoms attributable to the carotid territory affected by the stenotic artery. - Stenosis > 50% with neurological symptoms attributable to the carotid territory affected by the stenotic artery. Exclusion Criteria: - Any carotid revascularization technique other than eversion (carotid endarterectomy with patch, carotid resection-anastomosis or bypass). - Cardiac surgery combined with carotid surgery - Minor patients - Endovascular carotid surgery - Opposition to use patient's data |
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
University Hospital, Angers |
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Rate of restenosis | The main objective is to evaluate the rate of restenosis at doppler(defined as restenosis =50%(NASCET/ECST)) occurring at one year, according to the technical characteristics of the eversion. They are defined according to three distinct criteria: the circumferential nature of the endarterectomy at the level of the carotid bifurcation, the length of the endarterectomy and its depth in the plane of the intima. | one year | |
Secondary | Morbidity and mortality rate | Cumulative morbidity and mortality rate at 30 days defined by:
All-cause mortality within 30 days post-op Major neurological event defined as the occurrence of a stroke (focal signs lasting more than 24 hours, confirmed by brain imaging) |
30 days | |
Secondary | Major cardiological event | Major cardiological event defined by troponin elevation with chest pain (or equivalent symptom) and/or ECG changes in favor of myocardial ischemia | one year | |
Secondary | Minor neurological events | Minor neurological events: peripheral neurological and/or cranial nerve damage (tongue deviation, dysphonia, swallowing disorder). | one year |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT00774917 -
Numen Stent Assessment Using OCT Technique in a Single Center Study
|
Phase 2/Phase 3 | |
Recruiting |
NCT00496639 -
Stent vs. Angioplasty for Treatment of Thrombosed AV Grafts: Long-Term Outcomes
|
N/A | |
Recruiting |
NCT02592473 -
Prostate Artery Embolization (PAE) for Treatment of Benign Prostatic Hyperplasia
|
N/A | |
Completed |
NCT02063919 -
Association Between Confocal Laser Endomicroscopic (CLE) Features and Colorectal Mucosal Microbiome
|
N/A | |
Completed |
NCT00041925 -
Prevention of Autogenous Vein Graft Failure in Peripheral Artery Bypass Procedures
|
Phase 2/Phase 3 | |
Terminated |
NCT00086164 -
Prevention of Vascular Access Graft Failure in Patients With Chronic Renal Failure Requiring Hemodialysis
|
Phase 1/Phase 2 | |
Terminated |
NCT00819260 -
Harmonic Scalpel Vs. Electrocautery in Breast Reduction Surgery
|
N/A | |
Terminated |
NCT01033357 -
Safety Study of the Vascular Wrap Paclitaxel-Eluting Mesh for Hemodialysis Vascular Access
|
N/A | |
Withdrawn |
NCT02871050 -
Castleman Disease Collaborative Network Biobank
|
||
Active, not recruiting |
NCT02581137 -
Metformin Hydrochloride in Preventing Oral Cancer in Patients With an Oral Premalignant Lesion
|
Phase 2 | |
Completed |
NCT03268993 -
Effects of Avmacol® in the Oral Mucosa of Patients Following Curative Treatment for Tobacco-related Head and Neck Cancer
|
N/A | |
Active, not recruiting |
NCT01816438 -
A French Non Interventional Multicentric Cohort Study in Patients With Colorectal Dysplasia
|
||
Completed |
NCT01118260 -
Total Intravenous Anaesthesia (TIVA) Versus Spinal Anaesthesia in Patients Undergoing Transurethral Prostate Resection
|
Phase 4 | |
Completed |
NCT03718234 -
Subcutaneous Hydrocortisone Children With Congenital Adrenal Hyperplasia
|
Phase 1 | |
Withdrawn |
NCT01203371 -
Efficacy And Safety Study Of Naftopidil to Patients Treatment With LUTS
|
Phase 3 | |
Completed |
NCT02853968 -
Unlock the Cell: Castleman's Disease Flow Cytometry Study
|
||
Recruiting |
NCT00524823 -
Early Detection of Prostate Cancer by FACS
|
Phase 4 | |
Completed |
NCT03182959 -
Broccoli Sprout Extract in Preventing Recurrence in Patients With Tobacco-Related Head and Neck Squamous Cell Cancer
|
Early Phase 1 | |
Recruiting |
NCT02505256 -
Study Into Treatment of Hyperplasia of Mammary Glands
|
N/A |